JP2021502338A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502338A5
JP2021502338A5 JP2020524295A JP2020524295A JP2021502338A5 JP 2021502338 A5 JP2021502338 A5 JP 2021502338A5 JP 2020524295 A JP2020524295 A JP 2020524295A JP 2020524295 A JP2020524295 A JP 2020524295A JP 2021502338 A5 JP2021502338 A5 JP 2021502338A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020524295A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502338A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/059100 external-priority patent/WO2019090180A1/en
Publication of JP2021502338A publication Critical patent/JP2021502338A/ja
Publication of JP2021502338A5 publication Critical patent/JP2021502338A5/ja
Withdrawn legal-status Critical Current

Links

JP2020524295A 2017-11-03 2018-11-03 感染の治療のためのグリカン調製物 Withdrawn JP2021502338A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762581517P 2017-11-03 2017-11-03
US62/581,517 2017-11-03
US201862720924P 2018-08-21 2018-08-21
US62/720,924 2018-08-21
US201862731746P 2018-09-14 2018-09-14
US62/731,746 2018-09-14
PCT/US2018/059100 WO2019090180A1 (en) 2017-11-03 2018-11-03 Glycan preparations for the treatment of infection

Publications (2)

Publication Number Publication Date
JP2021502338A JP2021502338A (ja) 2021-01-28
JP2021502338A5 true JP2021502338A5 (https=) 2021-12-16

Family

ID=64564983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524295A Withdrawn JP2021502338A (ja) 2017-11-03 2018-11-03 感染の治療のためのグリカン調製物

Country Status (5)

Country Link
US (1) US20200352980A1 (https=)
EP (2) EP3703704A1 (https=)
JP (1) JP2021502338A (https=)
CN (1) CN111417398A (https=)
WO (1) WO2019090180A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1246600B (en) 2015-01-26 2020-04-09 Cadena Bio, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
EP3841127A2 (en) * 2018-08-21 2021-06-30 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof for reducing ammonia levels
KR20220007090A (ko) * 2019-05-08 2022-01-18 칼레이도 바이오사이언시즈, 인크. 올리고사카라이드 조성물 및 그의 사용 방법
CN110591962B (zh) * 2019-09-28 2020-11-06 华中农业大学 一种水虻肠道来源的奇异变形杆菌bsflg-cip5及其应用
US12508274B2 (en) 2020-07-17 2025-12-30 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use
CN112842997B (zh) * 2021-04-08 2022-08-12 青岛海洋生物医药研究院股份有限公司 一种同时抑制幽门螺旋杆菌和具核梭杆菌的口服海洋多糖纳米胶束及其制备方法和应用
EP4337031A4 (en) * 2021-05-13 2025-04-09 One Bio Inc Methods of use of oligosaccharide compositions for modulating microbiota and their metabolic products, and as therapeutics for health applications
CN113406253B (zh) * 2021-07-12 2023-04-18 青岛农业大学 一种苯丙烷代谢途径代谢物的液质联用分析方法及应用
US20240001258A1 (en) * 2022-07-01 2024-01-04 The Board Of Trustees Of The University Of Illinois Enhanced extraction of natural products from biomass
WO2024149375A1 (en) * 2023-01-13 2024-07-18 The Chinese University Of Hong Kong Synbiotic compositions for improving immunity and for treating atopic dermatitis
WO2025165991A1 (en) * 2024-01-31 2025-08-07 The Penn State Research Foundation Biopolymeric anti-antibiotics and methods for making and using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5085883A (en) 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
EP1596843A2 (en) 2003-01-28 2005-11-23 Purdue Research Foundation Slowly digestible starch
KR100857500B1 (ko) 2003-06-30 2008-09-08 클라사도 인크. 신규한 갈락토올리고사카라이드 조성물 및 그 제조방법
US7915235B2 (en) * 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
US9079171B2 (en) 2011-02-28 2015-07-14 Midori Usa, Inc. Polymeric acid catalysts and uses thereof
KR20150047583A (ko) 2012-08-24 2015-05-04 미도리 리뉴어블즈 인코퍼레이티드 중합체 촉매와 고체-지지된 촉매, 및 이러한 촉매를 사용하여 셀룰로오스 물질을 분해하는 방법
CN107001528A (zh) 2014-07-09 2017-08-01 米德瑞(美国)有限公司 低聚糖组合物及其制备方法
US9492473B2 (en) * 2015-01-26 2016-11-15 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
PT3071235T (pt) * 2015-01-26 2018-02-21 Kaleido Biosciences Inc Produtos terapêuticos de glicanos e respetivos métodos relacionados
CA2983236A1 (en) * 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
WO2016172658A2 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Microbiome regulators and related uses thereof
WO2017035412A1 (en) * 2015-08-25 2017-03-02 Kaleido Biosciences, Inc. Glycan compositions and uses thereof
US20210137964A1 (en) * 2016-07-13 2021-05-13 Kaleido Biosciences, Inc. Glycan compositions and methods of use
CA3046207A1 (en) * 2016-12-06 2018-06-14 Kaleido Biosciences, Inc. Glycan polymers and related methods thereof
US20210161942A1 (en) * 2017-07-13 2021-06-03 Kaleido Biosciences, Inc. Glycan compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2019099571A5 (https=)
JP2021502066A5 (https=)
JP2019030304A5 (https=)
JP2020042034A5 (https=)
JP2021028398A5 (https=)
JP2019068846A5 (https=)
JP2022028828A5 (https=)
JP2022025124A5 (https=)
JP2021185136A5 (https=)
JP2021518389A5 (https=)
JP2018154848A5 (https=)
JP2019031552A5 (https=)
JP2020040981A5 (https=)
JP2020534795A5 (https=)
JP2020007340A5 (https=)
JP2021038271A5 (https=)
JP2021500894A5 (https=)
JP2021503478A5 (https=)
JPWO2020148954A5 (https=)
JP2016196495A5 (https=)
JP2017214405A5 (https=)
JP2021502338A5 (https=)
JP2018135352A5 (https=)
JP2021524864A5 (https=)
JP2018111825A5 (https=)